×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
GeneticVariation
LHGDN
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancer.
19116992
2009
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
AlteredExpression
LHGDN
Suppression of androgen receptor signaling and prostate specific antigen expression by (-)-epigallocatechin-3-gallate in different progression stages of LNCaP prostate cancer cells.
18977589
2009
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Evaluation of molecular forms of prostate-specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy.
19003994
2009
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Transrectal ultrasound and prostate-specific antigen in prostate cancer.
19032406
2008
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Prostate-specific membrane antigen associates with anaphase-promoting complex and induces chromosomal instability.
18645024
2008
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
AlteredExpression
LHGDN
Ubiquitylation of epsilon-COP by PIRH2 and regulation of the secretion of PSA.
17721809
2008
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
GeneticVariation
LHGDN
PSA and androgen-related gene (AR, CYP17, and CYP19) polymorphisms and the risk of adenocarcinoma at prostate biopsy.
18491956
2008
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Establishment of CXCR4-small interfering RNA retrovirus vector driven by human prostate-specific antigen promoter and its biological effects on prostate cancer in vitro and in vivo.
18431597
2008
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
AlteredExpression
LHGDN
The use of prostate specific antigen (PSA) density in detecting prostate cancer in Chinese men with PSA levels of 4-10 ng/mL.
18446367
2008
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
GeneticVariation
LHGDN
Novel splice variants of prostate-specific antigen and applications in diagnosis of prostate cancer.
18222179
2008
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
GeneticVariation
LHGDN
Prostate-specific antigen and 17-hydroxylase polymorphic genotypes in patients with prostate cancer and benign prostatic hyperplasia.
17961073
2007
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
GeneticVariation
LHGDN
Is there an inter-relationship between prostate specific antigen, kallikrein-2 and androgen receptor gene polymorphisms with risk of prostate cancer in north Indian population?
17257635
2007
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
17641982
2007
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
GeneticVariation
LHGDN
Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin.
17593395
2007
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
GeneticVariation
LHGDN
PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.
17151093
2007
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
AlteredExpression
LHGDN
Regulation of prostate cancer cell growth and PSA expression by angiotensin II receptor blocker with peroxisome proliferator-activated receptor gamma ligand like action.
17440964
2007
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Usefulness of prostate-specific antigen nadir as predictor of androgen-independent progression of metastatic prostate cancer.
16398402
2006
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Correlation between serum prostate-specific antigen and alpha-1-antitrypsin in men without and with prostate cancer.
16581345
2006
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Overexpression of CXCL10 in human prostate LNCaP cells activates its receptor (CXCR3) expression and inhibits cell proliferation.
16934957
2006
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
GeneticVariation
LHGDN
Association of vitamin D receptor FokI polymorphism with prostate cancer risk, clinicopathological features and recurrence of prostate specific antigen after radical prostatectomy.
16708371
2006
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Free/Total PSA (F/T ratio) kinetics in patients with clinically localized prostate cancer undergoing radical prostatectomy.
15936010
2005
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
16172196
2005
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Serenoa repens (Permixon) inhibits the 5alpha-reductase activity of human prostate cancer cell lines without interfering with PSA expression.
15543614
2005
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
Biomarker
LHGDN
Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
16091872
2005
×
Entrez Id:
354
Gene Symbol:
KLK3
KLK3
Prostatic Neoplasms
0.400
AlteredExpression
LHGDN
Preferential production of latent transforming growth factor beta-2 by primary prostatic epithelial cells and its activation by prostate-specific antigen.
15389580
2005